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Dietary n-3 Fatty Acids Increase Spleen Size and 
Postendotoxin Circulating TNF in Mice; Role of Macrophages, 
Macrophage Precursors, and Colony-Stimulating Factor-11
Willem L. Blok,* Marella F. T. R. de Bruijn/ Pieter J. M. Leenen/ Wijnand M. C. Eling,* 
Nico van Rooijen,§ E. Richard Stanley,^ Wim A. Buurman," and Jos W. M. van der Meer2*
In experimental studies in mice, dietary supplementation with n-3 fatty acids (FA) alleviates inflammation and increases resis­
tance to infection. Nevertheless, TNF production capacity was found to be increased in n-3 FA-fed mice. We previously found 
increased relative spleen weights in n-3 FA-fed mice. In this study, the nature of this increased spleen size was further inves­
tigated. Spleen cellularity was increased significantly in mice fed n-3 FA (fish oil 15% w/w), compared with controls fed corn
oil (15%) or normal lab chow (p  < 0.05). Experiments with T cell-deficient nude mice and experiments using macrophage 
depletion through liposomal dichloromethylene-biphosphonate revealed that the increase in spleen cellularity is T cell inde­
pendent and largely due to macrophage accumulation in the spleen. Accumulation of marginal zone and red pulp macrophages 
was histologically and immunohistochemically confirmed, n-3 FA induced peripheral blood monocytosis and an aspecific 
increase in bone marrow cellularity. Postendotoxin circulating TNF concentrations were increased significantly in n-3 FA-fed 
mice compared with controls. Splenectomy did not abolish this increase in circulating TNF. However, after macrophage de­
pletion through liposomal dichloromethylene-biphosphonate, circulating TNF was not detectable after endotoxin challenge. 
Circulating concentrations of CSF-1 did not differ between the various experimental groups. It is suggested that the cellular 
changes observed relate to increased constitutive production of TNF. The Journal of Immunology, 1996, 157: 5569-5573.
atty acids (FA)3 such as eicosapentaenoic acid and doco- 
sahexaenoic acid are polyunsaturated (n-3) FA, in which 
the last double bond is located between the third and 
fourth carbon atom from the methyl end of the FA chain. Dietary 
supplementation with n-3 FA results in modification of the FA 
composition of the cell membranes, thereby reducing the produc­
tion and biologic activity of prostaglandins and leukotrienes (l). 
More recently, dietary supplementation with n-3 FA has been as­
sociated with modulations in the production of the proinflamma- 
tory cytokines IL-l and TNF, the principal polypeptide mediators 
of inflammation (2, 3).
In experimental studies, dietary supplementation with n-3 FA 
has been shown to alleviate inflammation in various clinical dis­
ease states and in animal models (4-11). Preliminary evidence 
indicates that dietary n-3 FA supplementation may increase resis­
tance to infection in multitrauma patients (12). n-3 FA increase 
survival following endotoxic shock or infections with live micro­
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organisms in various animal models (13-18), and dietary n-3 FA 
increase IL-l a and TNF production capacity of mouse peritoneal 
cells (15, 19, 20). In the course of our experiments in mice, we 
noticed a 1.5-fold increase in relative spleen weight in n-3 FA-fed 
mice compared with controls. Similar observations have been re­
ported by other groups studying mice or rats (21-23).
To elucidate the mechanism of the enhanced resistance to in­
fections and possibly relate this to the increased spleen weight in 
mice, we studied the effects of dietary n-3 FA on the cellular com­
position of spleens, peripheral blood, and bone marrow. In addi­
tion, the effects of dietary n-3 FA on circulating concentrations of 
endotoxin-induced TNF and steady state CSF-1 were investigated.
Materials and Methods
Mice
In most experiments, 6-wk-old female Swiss mice, approximate weight 
25 g, were used. The animals were housed in plastic cages (type II and type 
III; Macrolon, Beyer en Eggelaar, The Netherlands) under specific patho­
gen-free conditions at 23 ± 2°C and 7 ventilations/h. In some experiments, 
normal female BALB/c and T cell-deficient female BALB/c nude mice 
(nu/nu) were used. Nude mice were housed in cages covered with sterilized 
filter bonnets.
Diet
Mice were fed a fat-free standard reference diet as a dry powder, supple­
mented with 14% fish oil (FO) concentrate and 1% corn oil (FO group), 
15% com oil (CO), or normal lab chow. The FO concentrate used was 
EPAX 3000 TG, a kind gift of Pronova (Bergen, Norway). The FO con­
centrate contained 37.1% n-3 FA, i.e., 17.7% eicosapentaenoic acid and 
14.4% docosahexaenoic acid (w/w). D-alpha tocopherol (0.67 mg/g) and a 
natural mix of tocopherols (0.525 mg/g) were added to avoid auto-oxida- 
tion. CO was a commercialy available preparation (Mazola). CO (1%) was 
added to the FO diet to avoid essential FA deficiency. The FO concentrate 
was kept under strict anaerobic conditions until preparation of the diet to 
avoid auto-oxidation. Diets were prepared at least twice per week, and kept 
at 4°C until administration.
Copyright © 1996 by The American Association of Immunologists . 0022-1 767/96/$02.00
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Table I. Effect o f dietary n-3 FA on spleen, peripheral blood, and bone marrow cells
Fish oil
Diet Group 
Corn oil Normal P
Spleen
Relative spleen weight (mg/g) 5.9 ± 0.5 4.8 ± 0.3 4.6 ± 0.2 0.01
Spleen cellularity (X  108) 2.7 ± 0.2 2.0 ± 0.2 1.4 ± 0.5 0.02
B 220 positive spleen cells (%) 41 ± 4 36 ± 2 31 ± 6 0.04
Peripheral blood
Hematocrit 43 ± 2.6 42 ± 3.2 43 ± 1.6 NS
White blood cell count (X  106/ml) 12.2 ± 4.0 9.1 ± 1.9 7.9 ± 1.3 NS
Lymphocytes (%) 55 ± 8 69 ± 4 64 ± 5 NS
Granulocytes (%) 34 ± 8 25 ± 4 31 ± 6 NS
Monocytes (%) 11 ± 2 6 ± 1 5 ± 1 0.02
Bone marrow
Cellularity (X  106) 24 ± 5 21 ± 7 13 ± 5 0.02
M-CFC (No. macrophage precursors/1 O'4 NBMC) 58 ± 15 51 ± 17 77 ± 20 NS
M-clustFC (No. macrophage precursors/10‘‘ NBMC) 94 ± 22 80 ± 18 98 ± 27 NS
ER-MP 21 high (erythroid cells) (%) 22 ± 5 25 ± 3 22 ± 5 NS
ER-MP 58 high (myeloid cells) (%) 50 ± 7 50 ± 2 54 ± 6 NS
ER-MP 12 high/20 neg (committed progenitors) (%) 1.2 ± 0.3 1.7 ± 0.2 1.6 ± 0.5 NS
ER-MP 12 pos/20 pos (immature myeloid precursors) (%) 5.4 ± 1.2 5.6 ± 0.5 5.0 ± 1.2 NS
ER-MP 12 neg/20 high (monocytes) (%) 5.7 ± 0.9 6.2 ± 0.8 5.7 ± 1.2 NS
Spleen analysis
The mice were anesthesized with ether, and blood was taken from the 
retrobulbar vessels after eye extraction. The animals were killed by neck 
dislocation, and spleens were removed and weighed. Total body weight 
was determined immediately before bleeding, and relative spleen weight 
was calculated afterward. A suspension of spleen cells was made over a 
nylon filter, and cells were counted with a Coulter counter (Coulter Corp.. 
Hialeah, FL). The effect of dietary n-3 FA on spleen weight was deter­
mined in normal Swiss mice, normal BALB/c mice, and T cell-deficient 
nude BALB/c mice (nu/nu).
Spleen cells were phenotypically characterized with flow cytometry us­
ing a set of mAbs specific for mouse cells: 59-AD 2.2 delecting Thy-1 
(T lymphocytes), RA3 6B2 detecting B220 (B lymphocytes), H I29.19 
detecting MT4 (CD4-positive T lymphocytes), 53-6.72 detecting Ly-2 
(C D 8-positive T lymphocytes), KT3 (CD3-positive T lymphocytes), 
and F4/80 (macrophages). Details concerning these Abs can be found in 
Leenen et al. (24).
After immunohistochemical staining of spleen sections with RA3 6B2 
(anti-B220), a mAb specific for mouse B cells, the relative surface area of 
white pulp was quantitated using a Leitz Diaplan light microscope (Leitz, 
Wetzlar, Germany) and a Videoplan image-processing system (Kontron, 
Munich, Germany).
To analyze the role of mature phagocytic macrophages in the increase 
in spleen, size, mice were fed FO for 0, 2, or 4 wk. Subsequently the 
animals were injected i.v. in the tail vein with 1 mg of liposomal dichlo- 
romethylene-biphosphonate (C12MDP or clodronate), 24 h before LPS 
challenge, to deplete macrophages (25). Control animals receiving the 
same diet were injected simultaneously with saline. Liposomal C12MDP 
was prepared as described (25). Spleen histology was studied in treated and 
untreated animals to verify macrophage depletion.
Peripheral blood cells
Peripheral blood cell count was performed by separately determining he­
matocrit and the total white blood cell count (using Coulter counter). D if­
ferential white blood cell count was performed by quantifying the light 
scatter profile of nucleated cells.
Bone marrow analysis
Bone marrow was obtained from both femora of each mouse by flushing 
the femur shafts with 3 ml of culture medium (RPMI, Dutch modification; 
Flow Laboratories, Irvine, Scotland). Nucleated cells were counted with a 
Coulter counter. Soft agar cultures of bone marrow cells were stimulated 
with macrophage CSF for 2 wk, and the number of macrophage precursors 
in the original preparation was quantitated by counting the number of mac­
rophage colonies and clusters (<50 cells); macrophage colony-forming 
cells and macrophage cluster-forming cells are given per 104 nucleated 
bone marrow cells (26). Nucleated bone marrow cells were phenotypically 
characterized with flow cytometry using mAbs detecting Ags of mouse 
macrophage and granulocyte precursors. The mAbs were produced at the
Department of Immunology (Erasmus University, Rotterdam, The Neth­
erlands), as described (27). The following mAbs were used: ER-MP12 and 
ER-MP20, identifying subpopulations of macrophage precursors; ER- 
MP58, identifying myeloid cells; and ER-MP21, identifying transferrin 
receptor-expressing cells (28).
Postendotoxin circulating TNF
At a time period of 1.5 h after i.p. administration of 10 fig of LPS (Esch­
erichia coli, serotype 055:B5; Sigma Chemical Co., St. Louis, MO), mice 
were anesthesized with ether, and blood was taken from the retrobulbar 
vessels after eye extraction. Blood samples (approximately 1 ml) were 
mixed with 100 fi\ of EDTA solution (21.4 mg/ml of EDTA in H20 ) and 
kept on ice until centrifugation at 1500 X g for 5 min. Resultant plasma 
was isolated and stored at -20°C until assay.
TNF-a was measured by ELISA using TN3, a hamster mAb specific for 
murine TNF-a, and lymphotoxin, as described (29, 30).
In separate experiments, the effect of splenectomy on postendotoxin 
circulating TNF was studied. Splenectomy was performed after ether an­
esthesia in 4-wk-old mice, 2 wk before the animals were started on the 
experimental diets.
Colony-stimulating factor-1
CSF-1 was determined in unstimulated serum samples by specific RIA, as 
described in detail elsewhere (31). This assay is based on the competition 
by CSF-1 for the interaction between l25I-labeled, purified mouse L cell 
CSF-1 glycoprotein and a rabbit polyclonal Ab to purified L cell CSF-1 
(32), and is more sensitive than the conventional CSF-1 bioassay based on 
bone marrow colony formation. Assays were conducted in duplicate on 
20-/xl samples. The concentration of CSF-1 in U/ml (1 U =  12 pg) was 
determined with reference to a standard curve prepared using a stable, 
partially purified L cell CSF-1 preparation.
Statistical analysis
Differences between groups were analyzed using the Kruskal-Wallis non- 
parametric ANOVA test, corrected for ties. Results were considered sta­
tistically significant at p <  0.05.
Results
Effects o f FO supplementation on spleen cellularity
The effects of dietary n-3 FA on spleen, peripheral blood, and bone 
marrow cells are summarized in Table I. The following experi­
ments were done to elucidate the mechanisms of the increased 
spleen weight in FO-fed mice. After 4 wk of dietary supplemen­
tation with FO or CO, experimental Swiss mice were compared 
with control animals on normal lab chow. FO-fed mice had sig­
nificantly increased relative spleen weights (p =  0.01) and spleen
The Journal of Immunology 5571
bJO
bû
£
4-3
'S• rH
£
C
cd
ftca
cd
>
• H
'o
«
C
be
bfl
e
4-3
JCbjo
• rn
CD
£
C
CD
JD
ftC/3
CD
>
• i—i 4-3
ri50
ÎM
3 0 -
FIGURE 1. Time-effect relationships of dietary n-3 FA on relative 
spleen weight {A) and on postendotoxin circulating TNF (B). Relative 
spleen weight was increased significantly from 2 wk on FO diet, as was 
postendotoxin circulating TNF (n =  12).
cellularity (/; = 0.02). In separate experiments, time-effect rela­
tionships in these responses were investigated. Mice were studied 
simultaneously after 0, 2, 4, and 6 wk of dietary FO supplemen­
tation. Increases in spleen weight were most prominent after 2 wk, 
and appeared somewhat blunted after 6 wk (Fig. 1A). Similar re­
sults were obtained in normal BALB/c mice. To investigate 
whether the increase in spleen size was accounted for or mediated 
by T cells, T cell-deficient female BALB/c mice were fed FO for
0, 2, or 4 wk. Relative spleen weight was increased significantly 
from 2 wk on, indicating that the increase in spleen weight was 
independent of the presence of T cells (results not shown).
Phenotypic characterization of spleen cells using a set of mAbs 
revealed no percentual differences in T lymphocytes or macro­
phages between the various dietary groups. However, FO-fed mice 
had a small but significant increase in B220-positive B lympho­
cytes (Table I).
Pretreatment with liposomal C12MDP 24 h before endotoxin 
challenge did not significantly affect spleen weight. However, in 
mice that had been on FO diet for 2 or 4 wk, liposomal C12MDP 
resulted in a decrease in spleen weight (Fig. 2A). In these FO-fed 
mice, treatment with liposomal C12MDP resulted in spleen weights 
that were not significantly different from mice that had been on 
normal diet only. Depletion of marginal zone and red pulp mac­
rophages was histologically confirmed, but accurate quantitation of 
F4/80-positive macrophages was not possible in cell suspensions, 
in which their numbers were equal in control and FO-fed mice. 
However, for other reasons (see below), the results indicate that 
the increase in spleen weight in FO-fed mice is mainly attributable 
to an increase in the splenic macrophage population that is de­
pleted by pretreatment with liposomal C12MDP.
To a lesser extent, B lymphocytes seem to contribute to the 
increased spleen cellularity in FO-fed mice. Quantification of the 
relative surface area of red and white pulp in spleen sections in­
dicated a decrease in T and B cell-containing white pulp (Fig. 3).
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FIGURE 2. BALB/c mice were fed FO for 0, 2, or 4 wk. At the end of 
the diet period, subsets of mice were injected i.v. with liposomal 
CI2M DP 24 h before LPS challenge. In contrast to mice injected with 
saline, animals injected with liposomal CI2M DP did not show a sig­
nificant increase in relative spleen weight following 2 or 4 wk of FO 
supplementation {A). Postendotoxin circulating TNF was not detect­
able in the liposomal CI2MDP-treated mice (B). *, Indicates a statisti­
cally significant difference compared with mice that had no FO diet.
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FIGURE 3. Spleen sections were stained for B220, an Ag specifically 
expressed by mouse B cells. The relative surface area of white pulp 
was quantitated using a Leitz Diaplan light microscope and a Video­
plan image-processing system. The boundaries of white pulp areas 
could be established easily since B220 staining is confluent in the 
peripheral B cell zones of the white pulp, but only scattered in the red 
pulp. Relative surface areas are expressed as mean ± SD.
A significant number of B220-positive B cells, however, is also 
present in the red pulp. We therefore conclude that FO-fed mice 
had a significantly increased content of red pulp area, containing 
mainly macrophages. F4/80 staining of spleen sections, identifying 
the red pulp areas, confirmed the relative increase of the red pulp 
area in the FO-fed mice.
The effect o f FO supplementation on peripheral blood cells
To investigate a possible relation between circulating blood cells 
and changes in spleen cellularity, peripheral blood cells were quan­
titated. Hematocrit did not differ between the various treatment
Normal 
□ C12MDP *
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groups. White blood cell count was higher in FO-fed mice, but 
this difference did not reach statistical significance. Analysis of 
the 1 ight-scatter profile of peripheral blood cells showed a sig­
nificant increase in percentage of monocytes in FO-fed mice 
(/; = 0.02, n = 6).
• Ofe
The effect of FO supplementation on bone marrow cells
Possible relations between changes in spleen and peripheral blood 
cellularity and the cellular composition of bone marrow were in­
vestigated. Bone marrow cellularity was increased significantly in 
FO-fed mice compared with mice fed CO or normal lab chow. This 
increase in bone marrow cellularity was equally distributed over 
the various hemopoietic lineages, since differential flow-cytomet- 
ric analysis of bone marrow cells, using ER-MP12 and ER-MP20 
mAbs, showed no significant differences between the various ex- 
perimental groups (Table I). Moreover, soft agar cultures of bone 
marrow cells did not reveal a relative increase in macrophage pre­
cursors, measured as macrophage colony-forming cells or macro­
phage cluster-forming cells.
The effect of FO supplementation on postendotoxin TNF
To investigate the suggested increase in mononuclear phagocyte 
functionality, we measured circulating TNF concentrations after 
endotoxin challenge. Postendotoxin concentrations of circulating 
TNF were significantly higher in FO-fed mice than in control mice. 
Postendotoxin TNF was 10.4 ± 6.6 ng/ml in FO-fed mice, 2.2 ± 
1.4 in CO-fed mice, and 2.7 ± 1.3 in mice fed normal diet 
(mean ± SD, p <  0.05). In separate experiments, time-effect re­
lationships in TNF production and FO diet were investigated. Sim­
ilar to the increase in spleen weight, increases in postendotoxin 
circulating TNF were most prominent after 2 wk of FO diet, and 
appeared somewhat blunted after 6 wk (Fig. 1B). Postendotoxin 
TNF in T cell-deficient nude BALB/c mice was increased sisnif- 
icantly from 2 wk on, indicating that the increase in postendotoxin 
circulating TNF was independent of the presence of T cells (results 
not shown).
Splenectomy, performed 2 wk before starting on the FO-sup- 
plemented diet, did not influence the increase in postendotoxin 
circulating TNF concentrations after 2 and 4 wk of diet: at both 
time points, postendotoxin circulating TNF concentrations were 
increased significantly compared with baseline (results not shown). 
At baseline and at 2 and 4 wk of dietary FO supplementation, 
postendotoxin circulating TNF was not detectable in liposomal 
C12M DP-treated mice (Fig. 2B). These observations suggest that 
splenic macrophages, despite their accumulation after dietary FO 
supplementation, are not the most important contributors to the 
production of circulating TNF. On the other hand, the macrophage 
population that is depleted by liposomal C12MDP and that does not 
reside in the spleen appears to be the most important producer of 
postendotoxin circulating TNF.
The effect of FO supplementation on circulating 
concentrations of CSF-1
The mononuclear phagocyte growth factor, CSF-1, is required for 
the development of the majority of mouse macrophages (33). To 
accurately measure circulating concentrations of CSF-1, serum 
samples were subjected to a mouse CSF-1-specific RIA. In bio­
logic samples, this RIA detects only biologically active CSF-1 (32, 
34), including both glycoprotein and proteoglycan forms (35). Cir­
culating concentrations of immunoreactive CSF-1 did not differ 
among the various diet groups: 702 ± 89 U/ml in FO-fed mice, 
753 ± 96 in CO-fed mice, and 802 ± 158 in mice fed normal diet 
(mean ± SD, p = 0.40).
Discussion
The present study shows that dietary n-3 FA supplementation has 
a significant effect on the generation and distribution of mononu­
clear phagocytes in mice: n-3 FA induce a generalized increase in 
bone marrow cellularity, peripheral blood monocytosis, and accu­
mulation of macrophages in the spleen, leading to an increase in 
spleen size. What could be the mechanism of these n-3 FA-induced 
changes?
The aspecific increase in bone marrow cellularity without pref­
erential stimulation of monocytopoiesis is in accordance with our 
observation on CSF-1: this specific monocyte growth factor was 
not increased in the n-3 FA-fed mice. The generalized increase in 
bone marrow cellularity suggests that earlier, broad spectrum he­
mopoietic growth factors such as IL-3 and granulocyte-macro- 
phage CSF are involved. The production of these factors is largely 
regulated by proinflammatory cytokines including IL-1 (36, 37). 
We have shown previously that IL-1 a: production capacity is in­
creased in mice after dietary n-3 FA (15). Increased constitutive 
production of this cytokine may be involved in the increased bone 
marrow cellularity observed in the present study. Moreover, Pelus 
and others have shown that PGE2 has an important modulatory 
effect on hemopoiesis in mice: exogenous administration of PGE2 
reduced nucleated bone marrow and splenic cellularity, while 
blockade of PGE2 biosynthesis increased bone marrow and splenic 
cellularity, especially in the presence of IL-1 a: (38-42). These 
observations may partly explain the results obtained in the present 
study, since dietary supplementation with n-3 FA in mice basically 
leads to increased IL-1 a and a decreased PGE2 production 
capacity.
Peripheral blood monocytosis induced by dietary n-3 FA has not 
been described before, but may be induced through a feedback 
mechanism following the accumulation of macrophages in the red 
pulp of the spleen. It is apparently not due to increased concen­
trations of CSF-1. This is in accordance with the observation that 
the number of red pulp macrophages is reduced only slightly in 
CSF-1-deficient op/op mice (43). Other factors, including IL-3, 
granulocyte-macrophage CSF, and the proinflammatory cytokines, 
may be considered. The results of our experiments with macro­
phage depletion using liposomal C12MDP suggest that the ob­
served increase in spleen size following dietary FO supplementa­
tion is largely due to accumulation of macrophages in the spleen. 
The immunohistochemical staining of spleen sections with B220 
showed a decrease in the relative surface area of white pulp in the 
FO-fed mice, thereby supporting the concept of accumulation of 
red pulp macrophages in FO-fed mice. As regulator cells, macro­
phages are responsible for the growth of lymphoid organs such as 
the spleen. Since TNF is an important growth factor for lymphoid 
organs, increased endogenous TNF production in FO-fed mice 
may contribute to this effect (44). The phenotypic characterization 
of spleen cell suspensions using a set of mAbs is not suitable for 
the assessment of the number of macrophages in the spleen, since 
especially tissue-fixed macrophages are lost in the process of mak­
ing a cell suspension over a nylon filter. We therefore regard the 
concept that dietary FO supplementation leads to macrophage ac­
cumulation in the spleen as valid.
The increase in spleen size after dietary n-3 FA appeared to be 
accompanied by increased circulating concentrations of postendo­
toxin TNF. We and others have shown previously that peritoneal 
macrophages of mice fed n-3 FA have increased TNF production 
capacity at the level of the single cell (15, 20, 45). Since splenec­
tomy did not affect the increased TNF concentrations following 
dietary n-3 FA, macrophage accumulation in the spleen is not re­
sponsible for the increased TNF concentrations. Interestingly, 
macrophage depletion by liposomal C12MDP completely abolished
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postendotoxin circulating TNF. It might be expected that Kupffer 
cells of the liver, due to their sinusoidal location, might be a major 
target for the uptake of liposomal CUMDP. In fact, recent evidence 
indicates that macrophage depletion in mice results in a 50 to 70% 
reduction in TNF mRNA in the liver following endotoxin chal­
lenge (46). Therefore, the Kupifer cells may be the most important 
contributors to the production of postendotoxin TNF. Similar to 
peritoneal macrophages, Kupffer cells may have increased TNF 
production capacity at the single cell level following dietary n-3 
FA. We did not assess the number of Kupffer cells. The small 
increase in relative liver weight in FO-fed mice does not rule out 
a substantial increase in the number of Kupffer cells.
In conclusion, dietary n-3 FA supplementation in mice induces 
an aspecific increase in bone marrow cellularity, peripheral blood 
monocytosis, accumulation of macrophages in the spleen, and in­
creased postendotoxin circulating concentrations of TNF. The 
mechanism of these changes remains to be elucidated.
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